Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by SPCEO1on Oct 13, 2022 11:11am
171 Views
Post# 35022291

RE:RE:RE:RE:RE:Expectations too high. Reset your animus.

RE:RE:RE:RE:RE:Expectations too high. Reset your animus.I think the most logical interpretation is that they want to control the message and I am a loose cannon from their perspective as they cannot control how Iinterpret what they say and what I post here. They have a lot of old fashioned ideas in a world that is now dominated by social media which i have seen in a variety of circumstances already. Its just how they operate. I don't really communicate with them much at all any longer as it has just gotten too weird. There seems to be a very low tolerance for negative commentary at TH, which is sadly unavoidable in today's world of social media. If anyone posted here that they really enjoyed ice cream, you can be sure Pinnacle and his/her alter egos woould be quick to criticize that person for being such an idiot as to like ice cream.  If TH were smart, they would realize I provide a wonderful free service to their cause by sharing the info I got on those previous calls with all of you, who represent a significant part of their shareholder base.   

PWIB123 wrote: Why would they do that?  How should we interpret your decision not to participate and theirs to restrict communication?

SPCEO1 wrote: I will not be participating in that call today as they put some ground rules in place that meant I could not share with you, or even my clients, what they said on the call.  

LouisW wrote:
I remember you said that you or your friends meet with them quarterly, right? Maybe you guys can ask more for us.....they are very conservative people, they probably want to collect more data to convince their audience.

 




<< Previous
Bullboard Posts
Next >>